Introduction of HIV post-exposure prophylaxis for sexually abused children in Malawi

Archives of Disease in Childhood

Volumn 90, Issue 12, 2005, Pages 1297-1299

  Ellis, J C ^a   Ahmad, S ^a   Molyneux, E M ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CHILD; CHILD CARE; CHILD SEXUAL ABUSE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALAWI; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEROCONVERSION;

ADOLESCENT; ANTI-HIV AGENTS; CHILD; CHILD ABUSE, SEXUAL; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALAWI; MALE; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 28444460254     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2005.080432     Document Type: Article

References (21)

1. Department of Health. HIV post exposure prophylaxis: guidance from the UK Chief Medical Officer's Expert Advisory Group on AIDS. London, Department of Health, February 2004 (www.advisorybodies.doh.gov.uk/eaga/PDFS/ prophylaxisguidancefeb04.pdf).
2. CDC. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR 2001;50(RR-11):1-42.
3. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centre for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997;337:1485-90.
4. Giele CM, Maw R, Carne CA, et al. British Co-operative Clinical Group of the Medical Society for the Study of Venereal Diseases. Post-exposure prophylaxis for non-occupational exposure to HIV: current clinical practice and opinions in the UK, Sex Transm Inf 2002;78:130-2.
5. Havens PL, Committee on Pediatric AIDS. Post exposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus. Pediatrics 2003;111:1475-89.
6. Almeda J, Casabona J, Simon B, et al. Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe. Eurosurveillance 2004;9:35-40.
7. Centers for Disease Control and Prevention. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. MMWR Recomm Rep, 2005 (www.cdc.gov/mmwr/mmwr_rr. html).
8. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001;357:1149-53.
9. Gutman LT, Herman-Giddens ME, McKinney RE Jr. Pediatric acquired immunodeficiency syndrome. Barriers to recognising the role of child sexual abuse. Am J Dis Child 1993;147:775-80.
10. Pitche P, Kombate K, Gbadoe AD, et al. Sexually transmitted diseases in young children in Lome (Togo). Role of sexual abuse. Arch Pediatr 2001;8:25-31.
11. Angyo IA, Okpeh ES, Onah J. Paediatric AIDS in Jos, Nigeria. West Afr J Med 1998;17:268-72.
12. Menick DM, Ngoh F. Seroprevalence of HIV infection in sexually abused children in Cameroon. Med Trop 2003;63:155-8.
13. National AIDS Commission. National estimate of HIV/AIDS in Malawi in 2003, Lilongwe, Malawi, 2003.
14. Ministry of Health, Malawi. Treatment of AIDS: Guidelines for the use of antiretroviral therapy in Malawi, 1st edn. October 2003.
15. Thomas A, Forster G, Robinson A, et al. National guideline for the management of sexually transmitted infections in children and young people. Arch Dis Child 2003;88:303-11.
16. Tudor-Williams G. Post-exposure prophylaxis (PEP) guidelines for children exposed to blood-borne viruses. June 2003 (www.bhiva.org/chiva/).
17. Kistner U. Rape and post exposure prophylaxis in South Africa: a review 2003. Centre for AIDS Development, Research and Evaluation (CADRE), South Africa.
18. Wiebe ER, Comay SE, McGregor M, et al. Offering HIV prophylaxis to people who have been sexually assaulted: 16 months experience in a sexual assault service. CMAJ 2000;162:641-5.
19. Babl FE, Cooper ER, Damon B, et al. HIV postexposure prophylaxis for children and adolescents. Am J Emerg Med 2000;18:282-7.
20. Kahn JO, Martin JN, Roland ME, et al. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study. J Infect Dis 2001;183:707-14.
21. Limb S, Kawsar M, Forster GE. HIV post-exposure prophylaxis after sexual assault: the experience of a sexual assault service in London. Int J STD AIDS 2002;13:602-5.